Professional
Added to YB: 2024-08-29
Pitch date: 2024-08-28
BLFS [bullish]
BioLife Solutions, Inc.
-4.95%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.
Market Cap
$1.2B
Pitch Price
$25.66
Price Target
N/A
Dividend
N/A
EV/EBITDA
598.01
P/E
-63.15
EV/Sales
10.80
Sector
Life Sciences Tools and Services
Category
growth
Show full summary:
Conestoga Capital Portfolio Holding: BioLife Solutions, Inc.
BLFS: Biopreservation tools co. beat Q2 rev & EPS. Media in 15 approved therapies, 11 more expected in 12mo. Stirling freezer divesture a catalyst. Strong growth pipeline from new approvals, expansions & indications.
Read full article (1 min)